In situ assembly of enzyme inhibitors using extended tethering
10.1038/nbt786
Crossref journal-article
Springer Science and Business Media LLC
Nature Biotechnology (297)
Bibliography

Erlanson, D. A., Lam, J. W., Wiesmann, C., Luong, T. N., Simmons, R. L., DeLano, W. L., Choong, I. C., Burdett, M. T., Flanagan, W. M., Lee, D., Gordon, E. M., & O’Brien, T. (2003). In situ assembly of enzyme inhibitors using extended tethering. Nature Biotechnology, 21(3), 308–314.

Authors 12
  1. Daniel A. Erlanson (first)
  2. Joni W. Lam (additional)
  3. Christian Wiesmann (additional)
  4. Tinh N. Luong (additional)
  5. Robert L. Simmons (additional)
  6. Warren L. DeLano (additional)
  7. Ingrid C. Choong (additional)
  8. Matthew T. Burdett (additional)
  9. W. Michael Flanagan (additional)
  10. Dennis Lee (additional)
  11. Eric M. Gordon (additional)
  12. Tom O'Brien (additional)
References 39 Referenced 171
  1. McGovern, S.L., Caselli, E., Grigorieff, N. & Shoichet, B.K. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J. Med. Chem. 45, 1712–1722 (2002). (10.1021/jm010533y) / J. Med. Chem. by SL McGovern (2002)
  2. Huc, I. & Lehn, J.M. Virtual combinatorial libraries: dynamic generation of molecular and supramolecular diversity by self-assembly. Proc. Natl. Acad. Sci. USA 94, 2106–2110 (1997). (10.1073/pnas.94.6.2106) / Proc. Natl. Acad. Sci. USA by I Huc (1997)
  3. Lehn, J.M. & Eliseev, A. Dynamic combinatorial chemistry. Science 291, 2331–2332 (2001). (10.1126/science.1060066) / Science by JM Lehn (2001)
  4. Nicolaou, K.C. et al. Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target-accelerated combinatorial synthesis. Chem. Eur. J. 7, 3824–3843 (2001). (10.1002/1521-3765(20010903)7:17<3824::AID-CHEM3824>3.0.CO;2-1) / Chem. Eur. J. by KC Nicolaou (2001)
  5. Ramstrom, O. & Lehn, J.M. Drug discovery by dynamic combinatorial libraries. Nat. Rev. Drug Disc. 1, 26–32 (2002). (10.1038/nrd704) / Nat. Rev. Drug Disc. by O Ramstrom (2002)
  6. Lewis, W.G. et al. Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks. Angew. Chem. Int. Edn. Engl. 41, 1053–1057 (2002). (10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4) / Angew. Chem. Int. Edn. Engl. by WG Lewis (2002)
  7. Rowan, S.J., Cantrill, S.J., Cousins, G.R.L., Sanders, J.K.M. & Stoddart, J.F. Dynamic covalent chemistry. Angew. Chem. Int. Edn. Engl. 41, 898–952 (2002). (10.1002/1521-3773(20020315)41:6<898::AID-ANIE898>3.0.CO;2-E) / Angew. Chem. Int. Edn. Engl. by SJ Rowan (2002)
  8. Erlanson, D. et al. Site-directed ligand discovery. Proc. Natl. Acad. Sci. USA 97, 9367–9372 (2000). (10.1073/pnas.97.17.9367) / Proc. Natl. Acad. Sci. USA by D Erlanson (2000)
  9. Shuker, S.B., Hajduk, P.J., Meadows, R.P. & Fesik, S.W. Discovering high-affinity ligands for proteins: SAR by NMR. Science 274, 1531–1534 (1996). (10.1126/science.274.5292.1531) / Science by SB Shuker (1996)
  10. Thornberry, N.A. et al. A combinatorial approach defines specificities of members of the caspase family and Granzyme B. J. Biol. Chem. 272, 17907–17911 (1997). (10.1074/jbc.272.29.17907) / J. Biol. Chem. by NA Thornberry (1997)
  11. Rano, T.A. et al. A combinatorial approach for determining protease specificities: application to interleukin-1β converting enzyme. Chem. Biol. 4, 149–155 (1997). (10.1016/S1074-5521(97)90258-1) / Chem. Biol. by TA Rano (1997)
  12. Kaufmann, S.H. & Hengartner, M.O. Programmed cell death: alive and well in the new millennium. Trends Cell Biol. 11, 526–534 (2001). (10.1016/S0962-8924(01)02173-0) / Trends Cell Biol. by SH Kaufmann (2001)
  13. Utz, P. & Anderson, P. Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules. Cell Death Differ. 7, 589–602 (2000). (10.1038/sj.cdd.4400696) / Cell Death Differ. by P Utz (2000)
  14. Hengartner, M.O. The biochemistry of apoptosis. Nature 407, 770–776 (2000). (10.1038/35037710) / Nature by MO Hengartner (2000)
  15. Gervais, F. et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation. Cell 97, 395–406 (1999). (10.1016/S0092-8674(00)80748-5) / Cell by F Gervais (1999)
  16. Hotchkiss, R.S. et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1, 496–501 (2000). (10.1038/82741) / Nat. Immunol. by RS Hotchkiss (2000)
  17. McBride, C., McPhail, L. & Steeves, J. Emerging therapeutic targets in caspase-dependent disease. Emerg. Therapeutic Targets 3, 391–411 (1999). (10.1517/14728222.3.3.391) / Emerg. Therapeutic Targets by C McBride (1999)
  18. Yue, T.-L., Ohlstein, E. & Ruffolo, R. Apoptosis: a potential target for discovering novel therapies for cardiovascular diseases. Curr. Opin. Chem. Biol. 3, 474–480 (1999). (10.1016/S1367-5931(99)80069-6) / Curr. Opin. Chem. Biol. by T-L Yue (1999)
  19. Nicholson, D. From bench to clinic with apoptosis-based therapeutic agents. Nature 407, 810–816 (2000). (10.1038/35037747) / Nature by D Nicholson (2000)
  20. Lee, D. et al. Potent and selective nonpeptide inhibitors of caspases-3 and -7 inhibit apoptosis and maintain cell functionality. J. Biol. Chem. 275, 16007–16014 (2000). (10.1074/jbc.275.21.16007) / J. Biol. Chem. by D Lee (2000)
  21. Han, B. et al. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxia-ischemic brain injury. J. Biol. Chem. 277, 30128–30136 (2002). (10.1074/jbc.M202931200) / J. Biol. Chem. by B Han (2002)
  22. Dolle, R.E. et al. P1 aspartate-based peptide α-((2,6-dichlorobenzoyl)oxy)methyl ketones as potent time-dependent inhibitors of interleukin-1β converting enzyme. J. Med. Chem. 37, 563–564 (1994). (10.1021/jm00031a003) / J. Med. Chem. by RE Dolle (1994)
  23. Arkin, M. et al. Binding of small molecules to an adaptive protein:protein interface. Proc. Natl. Acad. Sci. USA, in press (2003). (10.1073/pnas.252756299)
  24. Mittl, P.R.E. et al. Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-asp-val-ala-asp fluoromethyl ketone. J. Biol. Chem. 272, 6539–6547 (1997). (10.1074/jbc.272.10.6539) / J. Biol. Chem. by PRE Mittl (1997)
  25. Margolin, N. et al. Substrate and inhibitor specificity of interleukin-1β-converting enzyme and related caspases. J. Biol. Chem. 272, 7223–7228 (1997). (10.1074/jbc.272.11.7223) / J. Biol. Chem. by N Margolin (1997)
  26. Garcia-Calvo, M. et al. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273, 32608–32613 (1998). (10.1074/jbc.273.49.32608) / J. Biol. Chem. by M Garcia-Calvo (1998)
  27. Slee, E.A., Adrain, C. & Martin, S.J. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 276, 7320–7326 (2001). (10.1074/jbc.M008363200) / J. Biol. Chem. by EA Slee (2001)
  28. Fry, D.W. et al. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. Proc. Natl. Acad. Sci. USA 95, 12022–12027 (1998). (10.1073/pnas.95.20.12022) / Proc. Natl. Acad. Sci. USA by DW Fry (1998)
  29. Tsou, H.R. et al. 6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity. J. Med. Chem. 44, 2719–2734 (2001). (10.1021/jm0005555) / J. Med. Chem. by HR Tsou (2001)
  30. Myers, J.K. & Widlanski, T.S. Mechanism-based inactivation of prostatic acid phosphatase. Science 262, 1451–1453 (1993). (10.1126/science.8248785) / Science by JK Myers (1993)
  31. Taylor, W.P., Zhang, Z.Y. & Widlanski, T.S. Quiescent affinity inactivators of protein tyrosine phosphatases. Bioorg. Med. Chem. 4, 1515–1520 (1996). (10.1016/0968-0896(96)00144-7) / Bioorg. Med. Chem. by WP Taylor (1996)
  32. Ham, S.W., Park, J., Lee, S.J. & Yoo, J.S. Selective inactivation of protein tyrosine phosphatase PTP1B by sulfone analogue of naphthoquinone. Bioorg. Med. Chem. Lett. 9, 185–186 (1999). (10.1016/S0960-894X(98)00725-2) / Bioorg. Med. Chem. Lett. by SW Ham (1999)
  33. Arabaci, G., Xiao-Chuan, G., Beebe, K.D., Coggeshall, K.M. & Pei, D. α-Haloacetophenone derivatives as photoreversible covalent inhibitors of protein tyrosine phosphatases. J. Am. Chem. Soc. 121, 5085–5086 (1999). (10.1021/ja9906756) / J. Am. Chem. Soc. by G Arabaci (1999)
  34. Carter, P.H. et al. Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α. Proc. Natl. Acad. Sci. USA 98, 11879–11884. (2001). (10.1073/pnas.211178398) / Proc. Natl. Acad. Sci. USA by PH Carter (2001)
  35. Choong, I.C. et al. Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based design. J. Med. Chem. 45, 5005–5022 (2002). (10.1021/jm020230j) / J. Med. Chem. by IC Choong (2002)
  36. Thornberry, N.A. et al. Inactivation of interleukin-1β converting enzyme by peptide (acyloxy)methyl ketones. Biochemistry 33, 3934–3940 (1994). (10.1021/bi00179a020) / Biochemistry by NA Thornberry (1994)
  37. Pflugrath, J.W. The finer things in X-ray diffraction data collection. Acta Crystallogr. D 55, 1718–1725 (1999). (10.1107/S090744499900935X) / Acta Crystallogr. D by JW Pflugrath (1999)
  38. Navaza, J. AMORE—an automated package for molecular replacement. Acta Crystallogr. A 50, 157–163 (1994). (10.1107/S0108767393007597) / Acta Crystallogr. A by J Navaza (1994)
  39. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991). (10.1107/S0108767390010224) / Acta Crystallogr. A by TA Jones (1991)
Dates
Type When
Created 22 years, 5 months ago (Feb. 28, 2003, 10:30 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 3:56 p.m.)
Indexed 3 months, 3 weeks ago (May 1, 2025, 9:03 a.m.)
Issued 22 years, 6 months ago (Feb. 3, 2003)
Published 22 years, 6 months ago (Feb. 3, 2003)
Published Online 22 years, 6 months ago (Feb. 3, 2003)
Published Print 22 years, 5 months ago (March 1, 2003)
Funders 0

None

@article{Erlanson_2003, title={In situ assembly of enzyme inhibitors using extended tethering}, volume={21}, ISSN={1546-1696}, url={http://dx.doi.org/10.1038/nbt786}, DOI={10.1038/nbt786}, number={3}, journal={Nature Biotechnology}, publisher={Springer Science and Business Media LLC}, author={Erlanson, Daniel A. and Lam, Joni W. and Wiesmann, Christian and Luong, Tinh N. and Simmons, Robert L. and DeLano, Warren L. and Choong, Ingrid C. and Burdett, Matthew T. and Flanagan, W. Michael and Lee, Dennis and Gordon, Eric M. and O’Brien, Tom}, year={2003}, month=feb, pages={308–314} }